Company Apricus Biosciences Inc Nasdaq
Equities
US03832V1098
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
16/05 | Seelos Therapeutics, Inc. announced that it expects to receive $1.137029 million in funding | CI |
14/05 | Seelos Therapeutics to Implement Reverse Stock Split to Regain Bourse Compliance | MT |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 0 | nan % | 2 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 2 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Raj Mehra
CEO | Chief Executive Officer | 64 | 01/87/01 |
Director of Finance/CFO | 52 | 01/19/01 | |
Karen Fusaro
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gopal Krishna
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 66 | - | |
Anthony Marciano
IRC | Investor Relations Contact | - | 01/17/01 |
Lucas Pilipski
PRN | Corporate Officer/Principal | - | 01/20/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 77 | 01/21/01 | |
Richard Pascoe
CHM | Chairman | 60 | 01/13/01 |
Daniel O'Connor
BRD | Director/Board Member | 59 | 01/19/01 |
Brian Lian
BRD | Director/Board Member | 58 | 01/19/01 |
Raj Mehra
CEO | Chief Executive Officer | 64 | 01/87/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,607,744 | 2,573,507 ( 98.69 %) | 0 | 98.69 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
REGNUM CORP. 98.82% | 22,680,000 | 98.82% | 725,760 $ |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- SEEL Stock
- Stock
- Company Apricus Biosciences Inc